Skip to content

Clinical trials

Phase 2 Idiopathic Pulmonary Fibrosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 2 Country / region: Germany Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20133
20141
20152
20161
20172
20181
20191
20202
20223
20234
20246
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated9
Recruiting5
Active, not recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Hoffmann-La Roche4
Avalyn Pharma Inc.2
Novartis Pharmaceuticals2
AbbVie1
Actelion1
Amgen1
AstraZeneca1
Biogen1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis34
Pulmonary Fibrosis6
Lung Diseases, Interstitial4
Idiopathic Interstitial Pneumonias3
Fibrosis2
Cough1
Cryptogenic Organizing Pneumonia1
Hamman-Rich Syndrome1
Hypertension, Pulmonary1
Lung Diseases1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.